Rather perplexing though, modulating LCN2 expression in human pancreatic cancer cells did not affect cell viability in vitro, but once engrafted LCN2-overexpressing tumors were smaller, poorly vascularized and had fewer metastases in an orthotopic nude mouse model (96). This evidence concerns the gene LCN2 and pancreatic neoplasm.